DELIVERY ORDER
Active36C26127N0083
Department of Veterans Affairs › 261-NETWORK CONTRACT OFFICE 21 (36C261)
$1.7M
obligated · signed 6 days ago
PET PSMA DOSES NDC: 71258-0022-01
Performance timeline
Start
Oct 1, 2026
End
Sep 30, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 30, 2027
PROGENICS PHARMACEUTICALS INC
Contract 36C26127N0083
UEI
YLYKVRPCTCR3
Parent Company
LANTHEUS HOLDINGS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$1,732,186
Base + Exercised Options
$1,732,186
Total Ceiling Value
$1,732,186
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 06
Awarding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
261-NETWORK CONTRACT OFFICE 21 (36C261)
Office
Funding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
261-NETWORK CONTRACT OFFICE 21 (36C261)
Office
Contract Vehicle
36F79725D0093
FSSDepartment of Veterans Affairs
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.